Canadian Cardiovascular Society – BayerResident Vascular Award
The Canadian Cardiovascular Society and Bayer Inc. have collaboratively created an award, entitled “CCS − Bayer Resident Vascular Award”. This Award is intended for Canadian clinical trainees (PGY 4-6) for a research project on any topic related to thrombosis, anticoagulation, stroke, or atrial fibrillation.
The program is particularly interested in research that has the potential to advance knowledge about or improve the care of patients at risk for vascular thrombotic or embolic events.
Applicants must be enrolled in a Canadian clinical training program (PGY 4-6).
Applicants must be available to travel to Vancouver to present their research projects to the judging panel during an accredited symposium presented at the Canadian Cardiovascular Congress (CCC), on October 22, 2017. Travel arrangements will be made for out of province finalists.
Submission deadline: September 15, 2017
Finalists Announcement: Early October 2017
Award Presented: October 22, 2017
Applicants are asked to submit a brief (three pages or less), proposal, including the following:
An evaluation committee chaired by Dr. Andrew Krahn and consisting of Drs. John Eikelboom, Jeffrey Healey, William McIntyre, Carlos Morillo and Roopinder Sandhu, will review applications and select the three most meritorious as finalists.
These three finalists will present their research project at a Canadian Cardiovascular Society accredited symposium to be held during the Canadian Cardiovascular Congress (CCC) in Vancouver, on October 22, 2017. During a 10 minute presentation, they will have the opportunity to discuss the research project and answer questions from the judging panel above.
Following the three presentations, each of the three finalists will be awarded a Vascular Award.